Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-FAPI-46 PET Imaging of CAFs in PDA
NCT05518903Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- Nov 2022
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga FAPI-46 in pancreatic ductal adenocarcinoma (PDAC), sponsored by Mayo Clinic. Started Nov 2022; status: recruiting.
02
Drugs
68Ga FAPI-46
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT05518903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05518903.